Antihypertensive medication classes and risk of incident dementia in primary care patients: a longitudinal cohort study in the NetherlandsResearch in context
Summary: Background: Hypertension is a modifiable risk factor for dementia affecting over 70% of individuals older than 60. Lowering dementia risk through preferential treatment with antihypertensive medication (AHM) classes that are otherwise equivalent in indication could offer a cost-effective, safe, and accessible approach to reducing dementia incidence globally. Certain AHM-classes have been associated with lower dementia risk, potentially attributable to angiotensin-II-receptor (Ang-II) stimulating properties. Previous study results have been inconclusive, possibly due to heterogeneous m... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2024 |
Reihe/Periodikum: | The Lancet Regional Health. Europe, Vol 42, Iss , Pp 100927- (2024) |
Verlag/Hrsg.: |
Elsevier
|
Schlagwörter: | Dementia / Alzheimer's disease / Hypertension / Antihypertensive medication / Angiotensin hypothesis / Primary care / Public aspects of medicine / RA1-1270 |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-29171702 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://doi.org/10.1016/j.lanepe.2024.100927 |